Identification of novel thiocarboxanilide derivatives that suppress a variety of drug-resistant mutant human immunodeficiency virus type 1 strains at a potency similar to that for wild-type virus.

Ítems similars

• Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives).
  per: Balzarini, J, et al.
  Publicat: (1995)
• Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1.
  per: Jiang, M, et al.
  Publicat: (1993)
• Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strains.
  per: Balzarini, J, et al.
  Publicat: (1995)
• Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins.
  per: Rice, A P, et al.
  Publicat: (1990)
• Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant.
  per: Steffy, K R, et al.
  Publicat: (1993)